Skip to main content
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Catalent, Inc. Common Stock (NY:CTLT)

63.48 UNCHANGED
Last Price Updated: 7:00 PM EST, Dec 17, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Catalent, Inc. Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
15 16 Next >
China's Response To Shield Economy From Real Estate Storm, Biden Targets Cancer, Diabetes Drugs In Controversial Medicare Price Battle, Google Collaborates With Nvidia In AI Expansion: Today's Top Stories
Bloomberg China Takes Drastic Measures To Shield Economy From Real Estate Storm 
Via Benzinga
Topics Artificial Intelligence Economy
Catalent (CTLT) Stock Gains on Elliott Deal
Catalent (CTLT) stock is getting a boost on Tuesday after the company reached an agreement with Elliott Investment Management. 
Via InvestorPlace
Beaten Down COVID-19 Vaccine Partner Stock Catalent Finalizes Deal With Activist Investor, Reports Mixed Q4 Earnings
Catalent Inc (NYSE: CTLT), valued at around $8 billion, has finalized a deal with activist investor Elliott Investment Management.  
Via Benzinga
Catalent Announces Governance Enhancements and New Initiatives to Drive Value
From Catalent, Inc.
Via Business Wire
Catalent Earnings Preview
 
Via Benzinga
What 19 Analyst Ratings Have To Say About Catalent
 
Via Benzinga
Analyst Ratings for Catalent
 
Via Benzinga
Catalent, Inc. Reports Preliminary Fourth Quarter and Fiscal 2023 Results
From Catalent, Inc.
Via Business Wire
Wegovy's Massive Demand: Novo Nordisk CEO Expresses Full Confidence In Catalent Amid Manufacturing Hurdles
Novo Nordisk A/S's (NYSE: NVO) CEO, Lars Fruergaard Jorgensen, expressed confidence in Catalent Inc's (NYSE: CTLT) capability to rectify its manufacturing issues related to its  
Via Benzinga
Why Novo Nordisk Stock Was Racing Higher on Wednesday
When you have a hot item on the market, it's wise to ramp up production. 
Via The Motley Fool
One Is Not Enough For Famed Weight Loss Drug: Novo Nordisk Taps Thermo Fisher To Ramp Up Wegovy Production
Novo Nordisk A/S (NYSE: NVO) has reportedly enlisted the services of Thermo Fisher Scientific Inc (NYSE: TMO) as its second contract manufacturer for its highly sought-after  
Via Benzinga
Catalent, Inc. Announces Fourth Quarter Fiscal Year 2023 Earnings Conference Webcast
From Catalent, Inc.
Via Business Wire
CATALENT ALERT: Bragar Eagel & Squire, P.C. is Investigating Catalent, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
Why Is Regeneron Pharmaceuticals Moving Higher Today?
Regeneron Pharmaceuticals Inc (NASDAQ: REGN) earned second-quarter adjusted EPS of $10.24, up 5% Y/Y, beating the $9.92 Stre 
Via Benzinga
Rising Dividend Make Zoetis a Doggone Winner
Investors that typically focus on other large cap pharmaceutical plays may wish to consider an alternative bet on pets with shares of Zoetis. 
Via MarketBeat
Catalent Appoints Lisa Evoli Senior Vice President and Chief Human Resources Officer
From Catalent, Inc.
Via Business Wire
Novo Nordisk's Wegovy Supply Delays: FDA Uncovers Catalent Factory Lapses Violating Safety Regulations
The production facility that fills the self-injection pens for the rapidly-growing weight-loss medication Wegovy from Novo Nordisk A/S (NYSE: NVO) has been found to have persistently violated U.S. 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For July 20, 2023
 
Via Benzinga
Tesla Recalls Over 17K EVs Over Camera & Seat Belt Issues, University Research Uncovers Unexpected Fluctuations In ChatGPT Capabilities, Juul Seeks FDA Nod For Next-Generation Vaporizer: Today's Top Stories
Benzinga Tesla Recalls More Than 17,000 EVs Over Camera, Seat Belt Issues 
Via Benzinga
NVDA Stock Alert; Wolfe Research Just Gave Nvidia a Big Vote of Confidence
Nvidia (NVDA) stock is in the news Thursday after the tech company's shares got new coverage from Wolfe Research analysts. 
Via InvestorPlace
CTLT Stock Alert: What to Know as Elliott Takes a Stake in Catalent
Catalent (CTLT) stock is on the move Thursday as investors react to activist investor Elliott Investment taking a stake in the company. 
Via InvestorPlace
Proxy Truces On The Rise At Catalent: Elliott Builds Significant Stake, Calls For Board Shake-Up
Elliott Investment Management, an activist shareholder, has reportedly acquired a substantial stake in Catalent Inc (NYSE: CTLT). They are now advocating for a significant overhaul of the contract... 
Via Benzinga
INVESTIGATION ALERT: Scott+Scott Attorneys at Law LLP Investigates Catalent, Inc.’s Directors and Officers for Breach of Fiduciary Duties – CTLT
From Scott+Scott Attorneys at Law LLP
Via Business Wire
Why Catalent Stock Flopped Today
The company takes the fall for a failed drug application. 
Via The Motley Fool
CATALENT ALERT: Bragar Eagel & Squire, P.C. is Investigating Catalent, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire, P.C.
Via Business Wire
Catalent Appoints Matti Masanovich Senior Vice President & Chief Financial Officer
From Catalent, Inc.
Via Business Wire
Top 5 Performing S&P 500 Stocks This Week: 2 Are AI Latecomers, 1 Was Nearly Sunk By Covid
 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For June 14, 2023
 
Via Benzinga
Advanced Micro Devices To Rally Around 17%? Here Are 10 Other Analyst Forecasts For Wednesday
Raymond James cut the price target for W. P. Carey Inc. (NYSE: WPC) from $85 to $78. Raymond James analyst RJ Milligan maintained an Outperform rating. W. P. Carey shares fell 0.3% to $70.11 in... 
Via Benzinga
Catalent Regains Compliance with NYSE Continued Listing Standards
From Catalent, Inc.
Via Business Wire
< Previous 1 2 3 4 5 6 7 8 9
...
15 16 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.